BCTX
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$3.09
−6.79%Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- -$1.24
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2696.7%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | — | -$1.24 | — | — |
| Jun 9, 2026 | — | -$0.99 | — | — |
| Mar 11, 2026 | — | -$2.58 | — | — |
| Dec 11, 2025 | — | -$4.35 | — | — |
| Jun 16, 2025 | -$18 | -$16 | Beat 6.82% | — |
| Mar 12, 2025 | -$19 | -$23 | Miss -20.10% | — |
| Dec 16, 2024 | -$0.30 | -$33 | Miss -10893.33% | — |
| Jun 14, 2024 | -$82 | $16 | Beat 120.00% | — |
| Mar 18, 2024 | -$30 | -$106 | Miss -254.95% | — |
| Dec 14, 2023 | -$27 | -$75 | Miss -177.73% | — |
| Jun 14, 2023 | -$54 | -$48 | Beat 11.10% | — |
| Mar 15, 2023 | -$55 | -$115 | Miss -108.11% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026